Effects of disulfiram and dopamine beta-hydroxylase knockout on cocaine-induced seizures

Meriem Gaval-Cruz, Jason P. Schroeder, L. Cameron Liles, Martin A Javors, David Weinshenker

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The antialcoholism drug disulfiram has shown recent promise as a pharmacotherapy for treating cocaine dependence, probably via inhibition of dopamine β-hydroxylase (DBH), the enzyme that catalyzes the conversion of dopamine (DA) to norepinephrine (NE). We previously showed that DBH knockout (Dbh -/-) mice, which lack NE, are susceptible to seizures and are hypersensitive to the psychomotor, rewarding, and aversive effects of cocaine, suggesting that disulfiram might exacerbate cocaine-induced seizures (CIS) by inhibiting DBH. To test this, we examined CIS in wild-type and Dbh -/- mice following administration of disulfiram or the selective DBH inhibitor nepicastat. We found that Dbh genotype had no effect on CIS probability or frequency, whereas disulfiram, but not nepicastat, increased the probability of having CIS in both wild-type and Dbh -/- mice. Both disulfiram and nepicastat increased CIS frequency in wild-type but not Dbh -/- mice. There were no genotype or treatment effects on serum cocaine levels, except for an increase in disulfiram-treated Dbh -/- mice at the highest dose of cocaine. These results suggest that disulfiram enhances CIS via two distinct mechanisms: it both increases CIS frequency by inhibiting DBH and increases CIS frequency in a DBH-independent manner.

Original languageEnglish (US)
Pages (from-to)556-562
Number of pages7
JournalPharmacology Biochemistry and Behavior
Volume89
Issue number4
DOIs
StatePublished - Jun 2008
Externally publishedYes

Fingerprint

Disulfiram
Dopamine beta-Hydroxylase
Cocaine
Seizures
Dopamine
Norepinephrine
Genotype
Cocaine-Related Disorders
Drug therapy
Mixed Function Oxygenases
Knockout Mice

Keywords

  • Cocaine
  • Disulfiram
  • Dopamine beta-hydroxylase
  • Nepicastat
  • Norepinephrine
  • Seizure

ASJC Scopus subject areas

  • Biochemistry
  • Behavioral Neuroscience
  • Pharmacology

Cite this

Effects of disulfiram and dopamine beta-hydroxylase knockout on cocaine-induced seizures. / Gaval-Cruz, Meriem; Schroeder, Jason P.; Liles, L. Cameron; Javors, Martin A; Weinshenker, David.

In: Pharmacology Biochemistry and Behavior, Vol. 89, No. 4, 06.2008, p. 556-562.

Research output: Contribution to journalArticle

Gaval-Cruz, Meriem ; Schroeder, Jason P. ; Liles, L. Cameron ; Javors, Martin A ; Weinshenker, David. / Effects of disulfiram and dopamine beta-hydroxylase knockout on cocaine-induced seizures. In: Pharmacology Biochemistry and Behavior. 2008 ; Vol. 89, No. 4. pp. 556-562.
@article{e517ea6a071745a4b16311b96cf207e6,
title = "Effects of disulfiram and dopamine beta-hydroxylase knockout on cocaine-induced seizures",
abstract = "The antialcoholism drug disulfiram has shown recent promise as a pharmacotherapy for treating cocaine dependence, probably via inhibition of dopamine β-hydroxylase (DBH), the enzyme that catalyzes the conversion of dopamine (DA) to norepinephrine (NE). We previously showed that DBH knockout (Dbh -/-) mice, which lack NE, are susceptible to seizures and are hypersensitive to the psychomotor, rewarding, and aversive effects of cocaine, suggesting that disulfiram might exacerbate cocaine-induced seizures (CIS) by inhibiting DBH. To test this, we examined CIS in wild-type and Dbh -/- mice following administration of disulfiram or the selective DBH inhibitor nepicastat. We found that Dbh genotype had no effect on CIS probability or frequency, whereas disulfiram, but not nepicastat, increased the probability of having CIS in both wild-type and Dbh -/- mice. Both disulfiram and nepicastat increased CIS frequency in wild-type but not Dbh -/- mice. There were no genotype or treatment effects on serum cocaine levels, except for an increase in disulfiram-treated Dbh -/- mice at the highest dose of cocaine. These results suggest that disulfiram enhances CIS via two distinct mechanisms: it both increases CIS frequency by inhibiting DBH and increases CIS frequency in a DBH-independent manner.",
keywords = "Cocaine, Disulfiram, Dopamine beta-hydroxylase, Nepicastat, Norepinephrine, Seizure",
author = "Meriem Gaval-Cruz and Schroeder, {Jason P.} and Liles, {L. Cameron} and Javors, {Martin A} and David Weinshenker",
year = "2008",
month = "6",
doi = "10.1016/j.pbb.2008.02.009",
language = "English (US)",
volume = "89",
pages = "556--562",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Effects of disulfiram and dopamine beta-hydroxylase knockout on cocaine-induced seizures

AU - Gaval-Cruz, Meriem

AU - Schroeder, Jason P.

AU - Liles, L. Cameron

AU - Javors, Martin A

AU - Weinshenker, David

PY - 2008/6

Y1 - 2008/6

N2 - The antialcoholism drug disulfiram has shown recent promise as a pharmacotherapy for treating cocaine dependence, probably via inhibition of dopamine β-hydroxylase (DBH), the enzyme that catalyzes the conversion of dopamine (DA) to norepinephrine (NE). We previously showed that DBH knockout (Dbh -/-) mice, which lack NE, are susceptible to seizures and are hypersensitive to the psychomotor, rewarding, and aversive effects of cocaine, suggesting that disulfiram might exacerbate cocaine-induced seizures (CIS) by inhibiting DBH. To test this, we examined CIS in wild-type and Dbh -/- mice following administration of disulfiram or the selective DBH inhibitor nepicastat. We found that Dbh genotype had no effect on CIS probability or frequency, whereas disulfiram, but not nepicastat, increased the probability of having CIS in both wild-type and Dbh -/- mice. Both disulfiram and nepicastat increased CIS frequency in wild-type but not Dbh -/- mice. There were no genotype or treatment effects on serum cocaine levels, except for an increase in disulfiram-treated Dbh -/- mice at the highest dose of cocaine. These results suggest that disulfiram enhances CIS via two distinct mechanisms: it both increases CIS frequency by inhibiting DBH and increases CIS frequency in a DBH-independent manner.

AB - The antialcoholism drug disulfiram has shown recent promise as a pharmacotherapy for treating cocaine dependence, probably via inhibition of dopamine β-hydroxylase (DBH), the enzyme that catalyzes the conversion of dopamine (DA) to norepinephrine (NE). We previously showed that DBH knockout (Dbh -/-) mice, which lack NE, are susceptible to seizures and are hypersensitive to the psychomotor, rewarding, and aversive effects of cocaine, suggesting that disulfiram might exacerbate cocaine-induced seizures (CIS) by inhibiting DBH. To test this, we examined CIS in wild-type and Dbh -/- mice following administration of disulfiram or the selective DBH inhibitor nepicastat. We found that Dbh genotype had no effect on CIS probability or frequency, whereas disulfiram, but not nepicastat, increased the probability of having CIS in both wild-type and Dbh -/- mice. Both disulfiram and nepicastat increased CIS frequency in wild-type but not Dbh -/- mice. There were no genotype or treatment effects on serum cocaine levels, except for an increase in disulfiram-treated Dbh -/- mice at the highest dose of cocaine. These results suggest that disulfiram enhances CIS via two distinct mechanisms: it both increases CIS frequency by inhibiting DBH and increases CIS frequency in a DBH-independent manner.

KW - Cocaine

KW - Disulfiram

KW - Dopamine beta-hydroxylase

KW - Nepicastat

KW - Norepinephrine

KW - Seizure

UR - http://www.scopus.com/inward/record.url?scp=41949100080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41949100080&partnerID=8YFLogxK

U2 - 10.1016/j.pbb.2008.02.009

DO - 10.1016/j.pbb.2008.02.009

M3 - Article

VL - 89

SP - 556

EP - 562

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 4

ER -